1. Home
  2. UPBD vs PLSE Comparison

UPBD vs PLSE Comparison

Compare UPBD & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPBD
  • PLSE
  • Stock Information
  • Founded
  • UPBD 1986
  • PLSE 2014
  • Country
  • UPBD United States
  • PLSE United States
  • Employees
  • UPBD N/A
  • PLSE N/A
  • Industry
  • UPBD Diversified Commercial Services
  • PLSE Medical/Dental Instruments
  • Sector
  • UPBD Consumer Discretionary
  • PLSE Health Care
  • Exchange
  • UPBD Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • UPBD 1.2B
  • PLSE 1.3B
  • IPO Year
  • UPBD 1995
  • PLSE 2016
  • Fundamental
  • Price
  • UPBD $20.55
  • PLSE $17.74
  • Analyst Decision
  • UPBD Buy
  • PLSE
  • Analyst Count
  • UPBD 4
  • PLSE 0
  • Target Price
  • UPBD $37.00
  • PLSE N/A
  • AVG Volume (30 Days)
  • UPBD 594.7K
  • PLSE 230.7K
  • Earning Date
  • UPBD 05-01-2025
  • PLSE 05-06-2025
  • Dividend Yield
  • UPBD 7.61%
  • PLSE N/A
  • EPS Growth
  • UPBD N/A
  • PLSE N/A
  • EPS
  • UPBD 2.21
  • PLSE N/A
  • Revenue
  • UPBD $4,320,564,000.00
  • PLSE N/A
  • Revenue This Year
  • UPBD $8.37
  • PLSE N/A
  • Revenue Next Year
  • UPBD $6.79
  • PLSE N/A
  • P/E Ratio
  • UPBD $9.30
  • PLSE N/A
  • Revenue Growth
  • UPBD 8.22
  • PLSE N/A
  • 52 Week Low
  • UPBD $20.08
  • PLSE $6.60
  • 52 Week High
  • UPBD $38.72
  • PLSE $25.00
  • Technical
  • Relative Strength Index (RSI)
  • UPBD 33.21
  • PLSE 59.13
  • Support Level
  • UPBD $20.06
  • PLSE $16.40
  • Resistance Level
  • UPBD $21.34
  • PLSE $16.12
  • Average True Range (ATR)
  • UPBD 1.38
  • PLSE 1.25
  • MACD
  • UPBD -0.11
  • PLSE 0.35
  • Stochastic Oscillator
  • UPBD 11.29
  • PLSE 90.24

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has three operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: